Dsc Advisors, L.P.’s Abbott Laboratories Position
Does Dsc Advisors, L.P. own Abbott Laboratories (ABT)? Not currently — the last reported position was 50.5K shares worth $6M in Q1 2024; the fund’s latest 13F (Q3 2024) no longer reports it.
Position Value
$6M
Q1 2024
Shares
50.5K
% of Portfolio
+9.18%
Quarters Held
16
position exited
Position History ABT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2024 | 50.5K | $6M | +9.18% |
| Q4 2023 | 72.9K | $8M | +13.25% |
| Q3 2023 | 69.7K | $7M | +8.66% |
| Q2 2023 | 41.4K | $5M | +6.77% |
| Q3 2022 | 2.3K | $226,000 | +0.23% |
| Q2 2022 | 3.3K | $360,000 | +0.36% |
| Q1 2022 | 3.5K | $411,000 | +0.14% |
| Q4 2021 | 1.9K | $262,000 | +0.20% |
| Q3 2021 | 2.1K | $243,000 | +0.25% |
| Q2 2021 | 1.9K | $225,000 | +0.16% |
| Q1 2021 | 3.0K | $365,000 | +0.23% |
| Q3 2020 | 2.0K | $221,000 | +0.15% |
| Q4 2019 | 4.8K | $416,000 | +0.20% |
| Q3 2019 | 3.9K | $326,000 | +0.06% |
| Q2 2019 | 3.2K | $272,000 | +0.05% |
| Q1 2019 | 3.5K | $281,000 | +0.05% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Dsc Advisors, L.P.’s full portfolio or all institutional holders of ABT.